First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Hits New 52-Week High – Should You Buy?

Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) reached a new 52-week high on Thursday . The company traded as high as GBX 2,530 and last traded at GBX 2,527, with a volume of 6076 shares. The stock had previously closed at GBX 2,492.50.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Trading Up 1.4%

The business has a 50 day moving average of GBX 2,366.55 and a two-hundred day moving average of GBX 2,110.18. The firm has a market cap of £1.04 billion, a P/E ratio of -2,297.27 and a beta of 0.44.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content. The company operates under the brand name of Blackbird. The company was founded in 1998 and is based in London, the United Kingdom.

Featured Stories

Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.